Filtered By:
Source: HSMN NewsFeed
Management: Marketing
Procedure: Heart Valve Surgery
This page shows you your search results in order of date.
Order by Relevance | Date
Total 1 results found since Jan 2013.
Claret Medical Announces First Patient Treated in U.S. Pivotal Trial Evaluating Cerebral Protection During Transcatheter Aortic Valve Replacement (TAVR)
Randomized Controlled SENTINEL Trial is the First in the U.S. to Study Capture and Removal of Debris Released During TAVR That May Otherwise Be the Source of Stroke
SANTA ROSA, Calif.--(Healthcare Sales & Marketing Network)--Claret Medical, Inc., a deve... Devices, Interventional CardiologyClaret Medical, Cerebral Protection, TAVR, transcatheter, aortic valve
Source: HSMN NewsFeed - October 6, 2014 Category: Pharmaceuticals Source Type: news
